跳至主要内容
临床试验/NCT02035592
NCT02035592已完成不适用

The Effects of Blueberry Anthocyanins on Insulin Resistance and Vascular, Lung and Cognitive Function in a Population With Metabolic Syndrome.

University of East Anglia8 个研究点 分布在 2 个国家目标入组 144 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
144
试验地点
8
主要终点
Insulin resistance

研究概览

简要总结

The purpose of this study is to determine the dose-dependent impact of 6 month freeze-dried blueberry powder intake on insulin sensitivity and resistance, cardiovascular disease risk factors, and lung and cognitive function in overweight and obese participants with metabolic syndrome. We will also examine acute post-prandial effects of blueberry intake (at baseline and at 6-months).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 74 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Men and postmenopausal women (≥ 1 year since last menstruation)
  • 50 to 75 years old
  • BMI of ≥ 25 kg/m2
  • 3 characteristics of metabolic syndrome i.e: Waist circumference ≥ 102 cm for men, ≥ 88 cm for women; Triglycerides ≥ 1.7 mmol/L (or drug treatment for elevated triglycerides); HDL-cholesterol < 1.0 mmol/L for men, < 1.3 mmol/L for women (or drug treatment for low HDL-cholesterol); Blood pressure ≥ 130 mm Hg systolic and/or ≥ 85 mm Hg diastolic blood pressure; Fasting blood glucose ≥ 5.56 mmol/L
  • Successful biochemical, haematological and urinalysis assessment at screening

排除标准

  • Current smokers, or ex-smokers ceasing < 6 months ago
  • Existing or significant past medical history of vascular disease or medical conditions likely to affect the study measures
  • Fructose intolerance or known allergies to the intervention treatments
  • On therapeutic diets or having experienced substantial weight loss within 3 months of screening
  • Taking flavonoid containing supplements (and unwilling to cease intake during, and 1 month preceding the trial)
  • Planning on altering consumption of vitamin supplements / fish oil capsules during the course of the study.
  • Prescribed hypoglycaemic, vasodilators or HRT medication.
  • Unsatisfactory biochemical, haematological or urinary assessment at screening, or measures considered to be counter indicative for the study
  • < 3 characteristics of the metabolic syndrome.
  • NB: REC approved NoSA granted to include those on anti-hypertensives (29JUL2014)

结局指标

主要结局

Insulin resistance

时间窗: Chronic (0 to 6 month)

Assessed, in the fasted state, via HOMA-IR calculation in all participants; indirect assessment.

次要结局

  • Insulin resistance(Chronic (0 to 6 month))
  • Lung function(Chronic (0 to 6 month))
  • Cognitive function(Chronic (0 to 6 month))
  • Liver fat and blood flow assessment(Chronic (0 to 6 month))
  • Blood pressure and blood vessel regulation(Chronic (0 to 6 month))
  • Acute +24 hour effect of single (26g) intervention intake, given with high fat challenge(Chronic (0 to 6 month))
  • Bio-availability(Chronic (0 to 6 month))
  • Metabolite phenotype effects(Chronic (0 to 6 month))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验